MX2008011204A - 1-amino-4-fenil-dihidroisoquinolinas sustituidas, metodo para su produccion, su uso como medicamento, y medicamentos que las contienen. - Google Patents
1-amino-4-fenil-dihidroisoquinolinas sustituidas, metodo para su produccion, su uso como medicamento, y medicamentos que las contienen.Info
- Publication number
- MX2008011204A MX2008011204A MX2008011204A MX2008011204A MX2008011204A MX 2008011204 A MX2008011204 A MX 2008011204A MX 2008011204 A MX2008011204 A MX 2008011204A MX 2008011204 A MX2008011204 A MX 2008011204A MX 2008011204 A MX2008011204 A MX 2008011204A
- Authority
- MX
- Mexico
- Prior art keywords
- medicaments containing
- dihydroisoquinolines
- medicament
- phenyl
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se refiere a compuestos de la fórmula (I) (ver fórmula (I)) en que R1 a R11 tienen los significados especificados en las reivindicaciones; Los medicamentos que contienen compuestos de este tipo son útiles en la prevención o el tratamiento de diversos trastornos; Los compuestos pueden emplearse, entre otros, para trastornos renales tales como insuficiencia renal aguda o crónica, para deficiencias de la función biliar, para deficiencias respiratorias tales como ronquido o apneas del sueño o para trastornos del sistema nervioso central.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006012544A DE102006012544A1 (de) | 2006-03-18 | 2006-03-18 | Substituierte 1-Amino 4-phenyl-dihydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
PCT/EP2007/001982 WO2007107245A1 (de) | 2006-03-18 | 2007-03-08 | Substituierte 1-amino-4-phenyl-dihydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008011204A true MX2008011204A (es) | 2008-09-11 |
Family
ID=38230001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008011204A MX2008011204A (es) | 2006-03-18 | 2007-03-08 | 1-amino-4-fenil-dihidroisoquinolinas sustituidas, metodo para su produccion, su uso como medicamento, y medicamentos que las contienen. |
Country Status (16)
Country | Link |
---|---|
US (1) | US8124621B2 (es) |
EP (1) | EP1999113B1 (es) |
JP (1) | JP5249918B2 (es) |
KR (1) | KR20080104321A (es) |
CN (1) | CN101405269A (es) |
AR (1) | AR059849A1 (es) |
AT (1) | ATE440084T1 (es) |
AU (1) | AU2007229094A1 (es) |
BR (1) | BRPI0708818A2 (es) |
CA (1) | CA2646227A1 (es) |
DE (2) | DE102006012544A1 (es) |
MX (1) | MX2008011204A (es) |
NO (1) | NO20084399L (es) |
TW (1) | TW200800905A (es) |
UY (1) | UY30217A1 (es) |
WO (1) | WO2007107245A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120088737A2 (en) * | 2009-10-02 | 2012-04-12 | Ajinomoto Co., Inc | Novel acyl guanidine derivatives |
BR112017000691B1 (pt) | 2014-07-25 | 2023-02-14 | Taisho Pharmaceutical Co., Ltd | Feniltetra-hidroisoquinolina substituído com heteroari-la, seu uso, medicamento, inibidores de nhe3, de absorção de sódio e de absorção de fósforo, promotor de secre-ção de água intestinal e fármaco profilático ou terapêu-tico para constipação |
CN109810174B (zh) * | 2017-11-21 | 2021-01-01 | 首都医科大学 | 异喹啉-3-甲酰-TARGD(aa)aa,其制备,抗静脉血栓活性和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9222253D0 (en) * | 1992-10-23 | 1992-12-09 | Celltech Ltd | Chemical compounds |
KR20030045184A (ko) * | 2000-11-14 | 2003-06-09 | 알타나 파마 아게 | 포스포디에스테라제 억제제로서 (디히드로)이소퀴놀린유도체 |
AU2002224835A1 (en) * | 2000-11-14 | 2002-05-27 | Byk Gulden Lomberg Chemische Fabrik G.M.B.H. | Dihydroisoquinolines as novel phosphodiesterase inhibitors |
DE10163914A1 (de) * | 2001-12-22 | 2003-07-03 | Aventis Pharma Gmbh | Substituierte 4-Phenyltetrahydroisochinolinium-Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
DE10312963A1 (de) * | 2003-03-24 | 2004-10-07 | Aventis Pharma Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
JP4794446B2 (ja) * | 2003-09-23 | 2011-10-19 | メルク・シャープ・エンド・ドーム・コーポレイション | イソキノリン系カリウムチャンネル阻害薬 |
AR045944A1 (es) * | 2003-09-24 | 2005-11-16 | Novartis Ag | Derivados de isoquinolina 1.4-disustituidas |
DE102005044817A1 (de) * | 2005-09-20 | 2007-03-22 | Sanofi-Aventis Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
-
2006
- 2006-03-18 DE DE102006012544A patent/DE102006012544A1/de not_active Withdrawn
-
2007
- 2007-03-08 JP JP2009500730A patent/JP5249918B2/ja not_active Expired - Fee Related
- 2007-03-08 KR KR1020087022834A patent/KR20080104321A/ko not_active Application Discontinuation
- 2007-03-08 MX MX2008011204A patent/MX2008011204A/es not_active Application Discontinuation
- 2007-03-08 EP EP07711844A patent/EP1999113B1/de not_active Not-in-force
- 2007-03-08 WO PCT/EP2007/001982 patent/WO2007107245A1/de active Application Filing
- 2007-03-08 DE DE502007001360T patent/DE502007001360D1/de active Active
- 2007-03-08 CA CA002646227A patent/CA2646227A1/en not_active Abandoned
- 2007-03-08 BR BRPI0708818-3A patent/BRPI0708818A2/pt not_active Application Discontinuation
- 2007-03-08 AT AT07711844T patent/ATE440084T1/de active
- 2007-03-08 AU AU2007229094A patent/AU2007229094A1/en not_active Abandoned
- 2007-03-08 CN CNA2007800096036A patent/CN101405269A/zh active Pending
- 2007-03-15 AR ARP070101053A patent/AR059849A1/es unknown
- 2007-03-15 TW TW096108849A patent/TW200800905A/zh unknown
- 2007-03-16 UY UY30217A patent/UY30217A1/es not_active Application Discontinuation
-
2008
- 2008-09-17 US US12/212,301 patent/US8124621B2/en not_active Expired - Fee Related
- 2008-10-20 NO NO20084399A patent/NO20084399L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200800905A (en) | 2008-01-01 |
US8124621B2 (en) | 2012-02-28 |
WO2007107245A1 (de) | 2007-09-27 |
KR20080104321A (ko) | 2008-12-02 |
DE502007001360D1 (de) | 2009-10-01 |
CA2646227A1 (en) | 2007-09-27 |
US20090118327A1 (en) | 2009-05-07 |
AU2007229094A1 (en) | 2007-09-27 |
JP5249918B2 (ja) | 2013-07-31 |
BRPI0708818A2 (pt) | 2011-06-14 |
ATE440084T1 (de) | 2009-09-15 |
DE102006012544A1 (de) | 2007-09-27 |
JP2009530323A (ja) | 2009-08-27 |
CN101405269A (zh) | 2009-04-08 |
NO20084399L (no) | 2008-12-15 |
UY30217A1 (es) | 2007-10-31 |
EP1999113B1 (de) | 2009-08-19 |
EP1999113A1 (de) | 2008-12-10 |
AR059849A1 (es) | 2008-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007003157A (es) | 4-feniltetrahidroisoquinolinas sustituidas, metodo para su produccion, su uso como medicamento y un medicamento que las contiene. | |
MY150702A (en) | Substituted 4-phenyltetrahydroisoquinonelines, method of producing them, their use as medicament, and also medicament containing them | |
TNSN07263A1 (en) | Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them | |
HRP20050843A2 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds | |
UA89787C2 (ru) | Фторгликозидные производные пиразолов, лекарственное средство, которое содержит их, и их применение | |
MX2008016134A (es) | Derivados de fenol para el tratamiento de enfermedades respiratorias. | |
MX2010006033A (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso. | |
MY148483A (en) | 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids, method for the production and use thereof as medicaments | |
MX2010004494A (es) | Uso de anticuerpos de trkb para el tratamiento de trastornos respiratorios. | |
JO2686B1 (en) | Vehicles | |
UA94944C2 (ru) | 2,4-диаминопиримидины как ингибиторы киназ, которые принимают участие в регуляции клеточного цикла | |
GEP20115342B (en) | New diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them | |
UA104988C2 (uk) | Похідні піроніндолу та спосіб їх отримання | |
PL1888514T3 (pl) | Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych | |
UA102238C2 (en) | 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof | |
IL176914A0 (en) | Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments | |
MX2008011204A (es) | 1-amino-4-fenil-dihidroisoquinolinas sustituidas, metodo para su produccion, su uso como medicamento, y medicamentos que las contienen. | |
WO2007035879A3 (en) | Combination s-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm | |
UA96951C2 (ru) | ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЯ КАК ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
UA99638C2 (ru) | Оксазолидиноны для лечения и/или профилактики сердечной недостаточности | |
WO2007107246A3 (de) | Substituierte 2-amino-4-phenyl-dihydrochnoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament | |
TW200731976A (en) | Use of tiotropium salts in the treatment of moderate persistent asthma | |
WO2004069806A3 (de) | Substituierte 2-aminoimidazole, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament | |
MX2009010805A (es) | Metodos y composiciones que comprenden desvenlafaxina o duloxetina para el tratamiento de trastornos de la respiracion relacionados con el sueño. | |
TW200507837A (en) | N-substituted (benzoimidazol-2-yl)phenylamines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |